COLLECTIVE REVIEW OF SMALL CARCINOMAS OF THE PANCREAS
COLLECTIVE REVIEW OF SMALL CARCINOMAS OF THE PANCREAS
复制标题
DOI：
10.1097/00000658-198601000-00013
复制
发表时间：
1986-01-01
影响因子：
9
通讯作者：
ETO, T
中科院分区：
文献类型：
--
作者：
TSUCHIYA, R;NODA, T;ETO, T
为了确定胰腺癌治疗和诊断中涉及的问题，进行了一项小胰腺癌(直径小于或等于2厘米)的集体研究。收集病例106例，并进行分析。结果如下：(1)小胰腺癌切除率99.0%，手术死亡率4%。(2)I期仅占44%，III、IV期占14%。(3)淋巴结受累30例，包膜受累20例，腹膜后受累12例，血管受累9%。(4)术后5年累计生存率为30.3%，I期为37.0%。(5)胰腺小肿瘤不一定是早期癌，但I期肿瘤可视为早期癌。(6)经皮肝穿胆道造影术和内窥镜逆行胰胆管造影术分别是有和无黄疸的主要诊断指标。(7)小胰腺癌尚无特异性单项血清检测。
To determine problems involved in the treatment and diagnosis of pancreatic cancer, a collective study of small carcinoma of the pancreas (2 cm or less in diameter) was performed. One hundred six cases were collected and analyzed. The results were as follows: (1) In small carcinoma of the pancreas, the resectability rate was 99.0% and the operative mortality rate was 4%. (2) Only 44% of the patients belonged to Stage I, and 14% belonged to Stage III or IV. (3) Lymph node involvement, capsular invasion, retroperitoneal invasion, and vascular invasion were found in 30, 20, 12, and 9% of the patients, respectively. (4) The postoperative cumulative 5-year survival rate was 30.3%, and that of Stage I was 37.0%. (5) A small-sized tumor of the pancreas is not always an early carcinoma, but a tumor in Stage I may be regarded as an early carcinoma. (6) Percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography were the main diagnostic indicators in cases with and without jaundice, respectively. (7) There was no specific single serum test for detecting small pancreatic cancer.